Harvard Bioscience, Inc.
HBIO
$6.04
$0.030.50%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 27.98% | 109.69% | 49.20% | 83.84% | 30.34% |
| Total Receivables | 8.11% | 7.92% | -5.63% | -4.40% | -11.95% |
| Inventory | -2.68% | -10.50% | -16.88% | -11.44% | -5.47% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 17.74% | -4.66% | -3.70% | -30.03% | -31.18% |
| Total Current Assets | 5.74% | 6.89% | -6.38% | -3.15% | -6.74% |
|
|
|||||
| Total Current Assets | 5.74% | 6.89% | -6.38% | -3.15% | -6.74% |
| Net Property, Plant & Equipment | -5.64% | 6.42% | 6.35% | 31.23% | 38.88% |
| Long-term Investments | 4.60% | -83.03% | -83.42% | -82.07% | -84.20% |
| Goodwill | 4.60% | -83.03% | -83.42% | -82.07% | -84.20% |
| Total Other Intangibles | -31.83% | -31.38% | -32.10% | -32.01% | -30.99% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -26.59% | -5.08% | 29.72% | 18.33% | 14.00% |
| Total Assets | -2.33% | -36.77% | -40.57% | -37.87% | -40.07% |
|
|
|||||
| Total Accounts Payable | 9.96% | -23.71% | -2.03% | -17.32% | -20.45% |
| Total Accrued Expenses | 12.95% | 57.46% | -14.43% | 2.65% | -29.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -95.85% | -96.00% | 649.06% | 660.09% | 660.16% |
| Total Finance Division Other Current Liabilities | 30.29% | 34.99% | 14.25% | 20.88% | -1.91% |
| Total Other Current Liabilities | 30.29% | 34.99% | 14.25% | 20.88% | -1.91% |
| Total Current Liabilities | -57.08% | -60.04% | 139.09% | 144.03% | 116.55% |
|
|
|||||
| Total Current Liabilities | -57.08% | -60.04% | 139.09% | 144.03% | 116.55% |
| Long-Term Debt | -- | 36,132.32% | -- | -99.86% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.05% | 7.85% | 9.33% | 48.46% | 58.66% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -31.60% | -12.92% | 10.63% | -10.71% | -4.13% |
| Total Liabilities | 4.50% | 4.79% | -3.02% | 4.37% | 0.96% |
|
|
|||||
| Common Stock & APIC | 1.24% | 1.31% | 0.83% | 1.16% | 1.57% |
| Retained Earnings | -4.70% | -35.88% | -34.07% | -37.46% | -38.62% |
| Treasury Stock & Other | 14.26% | 25.51% | 4.76% | 21.29% | 2.80% |
| Total Common Equity | -32.28% | -78.32% | -78.46% | -76.60% | -78.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -32.28% | -78.32% | -78.46% | -76.60% | -78.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -32.28% | -78.32% | -78.46% | -76.60% | -78.44% |
|
|
|||||